Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype

Reinhard Kalb, Kornelia Neveling, Holger Hoehn, Hildegard Schneider, Yvonne Linka, Sat Dev Batish, Curtis Hunt, Marianne Berwick, Elsa Callén, Jordi Surrallés, José A. Casado, Juan Bueren, Ángeles Dasí, Jean Soulier, Eliane Gluckman, C. Michel Zwaan, Rosalina Van Spaendonk, Gerard Pals, Johan P. De Winter, Hans Joenje & 4 others Markus Grompe, Arleen D. Auerbach, Helmut Hanenberg, Detlev Schindler

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

FANCD2 is an evolutionarily conserved Fanconi anemia (FA) gene that plays a key role in DNA double-strand-type damage responses. Using complementation assays and immunoblotting, a consortium of American and European groups assigned 29 patients with FA from 23 families and 4 additional unrelated patients to complementation group FA-D2. This amounts to 3%-6% of FA-affected patients registered in various data sets. Malformations are frequent in FA-D2 patients, and hematological manifestations appear earlier and progress more rapidly when compared with all other patients combined (FA-non-D2) in the International Fanconi Anemia Registry. FANCD2 is flanked by two pseudogenes. Mutation analysis revealed the expected total of 66 mutated alleles, 34 of which result in aberrant splicing patterns. Many mutations are recurrent and have ethnic associations and shared allelic haplotypes. There were no biallelic null mutations; residual FANCD2 protein of both isotypes was observed in all available patient cell lines. These analyses suggest that, unlike the knockout mouse model, total absence of FANCD2 does not exist in FA-D2 patients, because of constraints on viable combinations of FANCD2 mutations. Although hypomorphic mutations arie involved, clinically, these patients have a relatively severe form of FA.

Original languageEnglish
Pages (from-to)895-910
Number of pages16
JournalAmerican Journal of Human Genetics
Volume80
Issue number5
DOIs
StatePublished - May 2007

Fingerprint

Fanconi Anemia Complementation Group Proteins
Fanconi Anemia
Phenotype
Mutation
Genes
Fanconi Anemia Complementation Group D2 Protein
Pseudogenes
Immunoblotting
Knockout Mice
Haplotypes
Registries
Alleles

ASJC Scopus subject areas

  • Genetics

Cite this

Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. / Kalb, Reinhard; Neveling, Kornelia; Hoehn, Holger; Schneider, Hildegard; Linka, Yvonne; Batish, Sat Dev; Hunt, Curtis; Berwick, Marianne; Callén, Elsa; Surrallés, Jordi; Casado, José A.; Bueren, Juan; Dasí, Ángeles; Soulier, Jean; Gluckman, Eliane; Zwaan, C. Michel; Van Spaendonk, Rosalina; Pals, Gerard; De Winter, Johan P.; Joenje, Hans; Grompe, Markus; Auerbach, Arleen D.; Hanenberg, Helmut; Schindler, Detlev.

In: American Journal of Human Genetics, Vol. 80, No. 5, 05.2007, p. 895-910.

Research output: Contribution to journalArticle

Kalb, R, Neveling, K, Hoehn, H, Schneider, H, Linka, Y, Batish, SD, Hunt, C, Berwick, M, Callén, E, Surrallés, J, Casado, JA, Bueren, J, Dasí, Á, Soulier, J, Gluckman, E, Zwaan, CM, Van Spaendonk, R, Pals, G, De Winter, JP, Joenje, H, Grompe, M, Auerbach, AD, Hanenberg, H & Schindler, D 2007, 'Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype', American Journal of Human Genetics, vol. 80, no. 5, pp. 895-910. https://doi.org/10.1086/517616
Kalb, Reinhard ; Neveling, Kornelia ; Hoehn, Holger ; Schneider, Hildegard ; Linka, Yvonne ; Batish, Sat Dev ; Hunt, Curtis ; Berwick, Marianne ; Callén, Elsa ; Surrallés, Jordi ; Casado, José A. ; Bueren, Juan ; Dasí, Ángeles ; Soulier, Jean ; Gluckman, Eliane ; Zwaan, C. Michel ; Van Spaendonk, Rosalina ; Pals, Gerard ; De Winter, Johan P. ; Joenje, Hans ; Grompe, Markus ; Auerbach, Arleen D. ; Hanenberg, Helmut ; Schindler, Detlev. / Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. In: American Journal of Human Genetics. 2007 ; Vol. 80, No. 5. pp. 895-910.
@article{78d2adeafc9d4a1d8c2d457a5d0f746c,
title = "Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype",
abstract = "FANCD2 is an evolutionarily conserved Fanconi anemia (FA) gene that plays a key role in DNA double-strand-type damage responses. Using complementation assays and immunoblotting, a consortium of American and European groups assigned 29 patients with FA from 23 families and 4 additional unrelated patients to complementation group FA-D2. This amounts to 3{\%}-6{\%} of FA-affected patients registered in various data sets. Malformations are frequent in FA-D2 patients, and hematological manifestations appear earlier and progress more rapidly when compared with all other patients combined (FA-non-D2) in the International Fanconi Anemia Registry. FANCD2 is flanked by two pseudogenes. Mutation analysis revealed the expected total of 66 mutated alleles, 34 of which result in aberrant splicing patterns. Many mutations are recurrent and have ethnic associations and shared allelic haplotypes. There were no biallelic null mutations; residual FANCD2 protein of both isotypes was observed in all available patient cell lines. These analyses suggest that, unlike the knockout mouse model, total absence of FANCD2 does not exist in FA-D2 patients, because of constraints on viable combinations of FANCD2 mutations. Although hypomorphic mutations arie involved, clinically, these patients have a relatively severe form of FA.",
author = "Reinhard Kalb and Kornelia Neveling and Holger Hoehn and Hildegard Schneider and Yvonne Linka and Batish, {Sat Dev} and Curtis Hunt and Marianne Berwick and Elsa Call{\'e}n and Jordi Surrall{\'e}s and Casado, {Jos{\'e} A.} and Juan Bueren and {\'A}ngeles Das{\'i} and Jean Soulier and Eliane Gluckman and Zwaan, {C. Michel} and {Van Spaendonk}, Rosalina and Gerard Pals and {De Winter}, {Johan P.} and Hans Joenje and Markus Grompe and Auerbach, {Arleen D.} and Helmut Hanenberg and Detlev Schindler",
year = "2007",
month = "5",
doi = "10.1086/517616",
language = "English",
volume = "80",
pages = "895--910",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype

AU - Kalb, Reinhard

AU - Neveling, Kornelia

AU - Hoehn, Holger

AU - Schneider, Hildegard

AU - Linka, Yvonne

AU - Batish, Sat Dev

AU - Hunt, Curtis

AU - Berwick, Marianne

AU - Callén, Elsa

AU - Surrallés, Jordi

AU - Casado, José A.

AU - Bueren, Juan

AU - Dasí, Ángeles

AU - Soulier, Jean

AU - Gluckman, Eliane

AU - Zwaan, C. Michel

AU - Van Spaendonk, Rosalina

AU - Pals, Gerard

AU - De Winter, Johan P.

AU - Joenje, Hans

AU - Grompe, Markus

AU - Auerbach, Arleen D.

AU - Hanenberg, Helmut

AU - Schindler, Detlev

PY - 2007/5

Y1 - 2007/5

N2 - FANCD2 is an evolutionarily conserved Fanconi anemia (FA) gene that plays a key role in DNA double-strand-type damage responses. Using complementation assays and immunoblotting, a consortium of American and European groups assigned 29 patients with FA from 23 families and 4 additional unrelated patients to complementation group FA-D2. This amounts to 3%-6% of FA-affected patients registered in various data sets. Malformations are frequent in FA-D2 patients, and hematological manifestations appear earlier and progress more rapidly when compared with all other patients combined (FA-non-D2) in the International Fanconi Anemia Registry. FANCD2 is flanked by two pseudogenes. Mutation analysis revealed the expected total of 66 mutated alleles, 34 of which result in aberrant splicing patterns. Many mutations are recurrent and have ethnic associations and shared allelic haplotypes. There were no biallelic null mutations; residual FANCD2 protein of both isotypes was observed in all available patient cell lines. These analyses suggest that, unlike the knockout mouse model, total absence of FANCD2 does not exist in FA-D2 patients, because of constraints on viable combinations of FANCD2 mutations. Although hypomorphic mutations arie involved, clinically, these patients have a relatively severe form of FA.

AB - FANCD2 is an evolutionarily conserved Fanconi anemia (FA) gene that plays a key role in DNA double-strand-type damage responses. Using complementation assays and immunoblotting, a consortium of American and European groups assigned 29 patients with FA from 23 families and 4 additional unrelated patients to complementation group FA-D2. This amounts to 3%-6% of FA-affected patients registered in various data sets. Malformations are frequent in FA-D2 patients, and hematological manifestations appear earlier and progress more rapidly when compared with all other patients combined (FA-non-D2) in the International Fanconi Anemia Registry. FANCD2 is flanked by two pseudogenes. Mutation analysis revealed the expected total of 66 mutated alleles, 34 of which result in aberrant splicing patterns. Many mutations are recurrent and have ethnic associations and shared allelic haplotypes. There were no biallelic null mutations; residual FANCD2 protein of both isotypes was observed in all available patient cell lines. These analyses suggest that, unlike the knockout mouse model, total absence of FANCD2 does not exist in FA-D2 patients, because of constraints on viable combinations of FANCD2 mutations. Although hypomorphic mutations arie involved, clinically, these patients have a relatively severe form of FA.

UR - http://www.scopus.com/inward/record.url?scp=34247576595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247576595&partnerID=8YFLogxK

U2 - 10.1086/517616

DO - 10.1086/517616

M3 - Article

VL - 80

SP - 895

EP - 910

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 5

ER -